An observational study in Dementia, Mild Cognitive Impairment and Stroke, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-02-23.
Sponsored by Norwegian University of Science and Technology · Observational
A prospective observational multicenter study aiming to describe incidence, and identify predictors for development of poststroke dementia (PSD) and mild cognitive impairment (MCI) after stroke
About 15000 Norwegians suffer a stroke every year and 2/3 will be more or less disabled. In addition to motor impairments and comorbidities, disability after stroke is often related to post stroke dementia (PSD) or mild neurocognitive disorder (NCD). However, these problems are hardly addressed in stroke or dementia research and frequently ignored in clinical practise. In the Nor-COAST study an interdisciplinary research group will collaborate to establish a research platform across all Norwegian Health Authorities. The overall aim of the study is to improve competence on PSD and NCD in order to improve individual health outcomes following a stroke. The specific objectives are to determine the incidence of PSD and NCD and the consequences on function and use of health care services and to enhance the early detection of PSD and NCD by identifying a set of risk factors, ranging from genetics to physical activity. The incidence and impact of PSD and NCD on function and use of health care services, medication and life-style changes are important when planning future health care services. Tools identifying patients at risk might improve diagnostic work up and together with knowledge on pathogenic aspects it will contribute to future treatment and prevention of PSD and NCD.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 816 is above the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with acute stroke
Exclusion Criteria:
Score on the Montreal cognitive assessment (MOCA)
Performance based test
Time frame: 18 months
Score on the Montreal cognitive assessment (MOCA)
Performance based test
Time frame: 3 months
Time spent in upright position
measured by bodyworn sensors
Time frame: 3 months
Time spent in upright position
measured by bodyworn sensors
Time frame: 18 months
Brain Imaging
MRI
Time frame: 18 months
Score on Short Physical Performance Battery (sppb)
Performance based test for mobility and lower extremity function
Time frame: 3 months
Score on Short Physical Performance Battery (sppb)
Physical function by performance based tests
Time frame: 18 months
Selfreported habits concerning smoking, alcohol, diet and medication using standardised questionnaires
Time frame: 3 months
Selfreported habits concerning smoking, alcohol, diet and medication using standardised questionnaires
Time frame: 18 months
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology